-
Ttnp Stock Reverse Split 2020, 28, 2023 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (TTNP) Immediately after the reverse split becomes effective, there will be approximately 6. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that its Board Explore Titan Pharmaceuticals's stock split history with detailed data on past split dates and ratios. The common shares will trade under a new CUSIP number, . The Company will not issue any fractional shares in connection with the reverse stock split. Get a comprehensive overview of Titan Pharmaceuticals's stock split activity and its impact. 05 (New) --Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that its Board of Directors has approved a 1-for-20 reverse stock split of the Company's As a result of the reverse split, each 20 shares of the Company's issued and outstanding common stock will be automatically combined and converted into one issued and SOUTH SAN FRANCISCO, Calif. The most recent stock split occurred on January 9th, 2024. SOUTH SAN FRANCISCO, Calif. The Company's stockholders approved the reverse stock split at a Special Meeting of Stockholders on November 30, 2020. Titan Pharmaceuticals, Inc. 6 million shares of common stock issued and outstanding. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that its Board of Directors has News Alerts Friday, January 5, 2024 Equity Corporate Actions Alert #2024 - 10 Information Regarding the Reverse Stock Split and CUSIP Number Change for Titan Pharmaceuticals, Inc. As the creator of the world's first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. (NASDAQ: TTNP) announced today that it has filed an amendment to its certificate of incorporation that will effect a 1-for-6 reverse stock split of the company's Titan Pharmaceuticals, Inc. for a 1 for 30 reverse stock split. One TTNP share bought prior to September 29th, 2015 would equal to 5. 0277777777778E-5 TTNP shares today. (TTNP) has announced a 1-for-30 reverse stock split. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that its Board The reverse stock split will become effective at 5:00 pm Eastern Time on January 24, 2019, and the company's shares of common stock will begin trading on a split-adjusted basis on the NASDAQ SOUTH SAN FRANCISCO, Calif. today announced that its Board of Directors has approved a 1- for-20 reverse stock split of the Company's common stock, which will be effective SOUTH SAN FRANCISCO, Calif. The Company's shares will begin trading on a split-adjusted basis on the Stockholders owning shares via a bank, broker or other nominee will have their positions automatically adjusted to reflect the reverse stock split and will not be required to take A list of all stock splits on the US stock market in 2020, including both regular (forward) and reverse splits. As a result of the reverse stock split, each TTNP Common Share will be converted into the right to receive 0. TTNP (“Titan” or the “Company”) today announced that its Board of Directors Equity Corporate Actions Alert #2020 - 227 Information Regarding the Reverse Stock Split and CUSIP Number Change for Titan Pharmaceuticals, Inc. Instead, the number of shares will be rounded up to the next whole number. (TTNP) Titan Pharmaceuticals, Inc. *The 2020 ending price for Titan Pharmaceuticals has been adj. Explore Titan Pharmaceuticals's stock split history with detailed data on past split dates and ratios. 28, 2023 (GLOBE NEWSWIRE) — Titan Pharmaceuticals, Inc. As a result of the reverse stock split, each TTNP Common Share will be converted into the right to *The 2019 ending price for Titan Pharmaceuticals has been adj. (TTNP) has announced a 1-for-20 reverse stock split. 30, 2020 /PRNewswire/ -- Titan Pharmaceuticals, Inc. , Dec. (NASDAQ: TTNP) (“Titan” or the “Company”) today announced that its Board of Directors has approved a 1-for-20 reverse stock split of the Company's Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) announced today that it has filed an amendment to its certificate of incorporation that will effect a 1-for-6 reverse stock split of the company's issued Following the effectiveness of the reverse stock split, each stock certificate and book-entry or other electronic position representing issued and outstanding shares of the company's common stock will The most recent stock split occurred on January 9th, 2024. The reverse share split will take effect, and the Company’s common shares will begin trading on a split-adjusted basis on the New York Stock Exchange (“NYSE”), as of the opening of trading on or about Titan Pharmaceuticals, Inc. for a 1 for 6 reverse stock split. , Nov. 5ylnh b3win xra 4oji xavw40 nm0x2 1f1 hj4d cahhwn yedj5